Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Manufacturing
Granules hit with FDA warning letter over production woes
Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a new FDA warning letter.
Fraiser Kansteiner
Mar 5, 2025 8:38am
FDA hits Piramal with 6-observation Form 483 at India API plant
Feb 26, 2025 10:22am
FDA hits 2 Indian API makers with warning letters, import alerts
Feb 20, 2025 9:05am
Aragen snares $100M investment to expand its operations
Jan 14, 2025 7:50am
Lilly adds another capability center in India, plans hires
Jan 10, 2025 11:09am
Indian CDMO Anthem Biosciences files for $397M IPO
Jan 8, 2025 3:05pm
